Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Nix

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
DICP : the Annals of Pharmacotherapy|October 1, 1991
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman
Hospital Pharmacy|March 11, 1985
Intravenous nitroglycerin delivery: dynamics and cost considerationsD E Nix, W N Tharpe, G E Francisco
Antimicrobial Agents and Chemotherapy|March 1, 1993
The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactionsR C Li, J J Schentag, D E Nix
Journal of Pharmaceutical Sciences|July 1, 1994
Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coliR C Li, D E Nix, J J Schentag
Pharmaceutical Research|June 1, 1994
Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activityR C Li, D E Nix, J J Schentag
The New England Journal of Medicine|September 27, 1984
No false "Hemoccult" reaction with ranitidineJ M DeVito, D E Nix, J J Schentag
Pharmacotherapy|January 1, 1992
Mathematic modeling of drug disposition and postdialysis rebound in patients requiring hemodialysisJ M Spivey, R A Blum, D E Nix
Diagnostic Microbiology and Infectious Disease|November 1, 2001
In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinationsT S Krueger, E A Clark, D E Nix
Antimicrobial Agents and Chemotherapy|December 1, 1994
Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similarJ M Hyatt, D E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
DICP : the Annals of Pharmacotherapy|October 1, 1991
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycinJ J Schentag, D E Nix, M H Adelman
Hospital Pharmacy|March 11, 1985
Intravenous nitroglycerin delivery: dynamics and cost considerationsD E Nix, W N Tharpe, G E Francisco
Antimicrobial Agents and Chemotherapy|March 1, 1993
The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactionsR C Li, J J Schentag, D E Nix
Journal of Pharmaceutical Sciences|July 1, 1994
Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coliR C Li, D E Nix, J J Schentag
Pharmaceutical Research|June 1, 1994
Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activityR C Li, D E Nix, J J Schentag
The New England Journal of Medicine|September 27, 1984
No false "Hemoccult" reaction with ranitidineJ M DeVito, D E Nix, J J Schentag
Pharmacotherapy|January 1, 1992
Mathematic modeling of drug disposition and postdialysis rebound in patients requiring hemodialysisJ M Spivey, R A Blum, D E Nix
Diagnostic Microbiology and Infectious Disease|November 1, 2001
In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinationsT S Krueger, E A Clark, D E Nix
Antimicrobial Agents and Chemotherapy|December 1, 1994
Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similarJ M Hyatt, D E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
Pageof 8